The 3D screen printing technology of Laxxon Medical Corp. provides pharmaceutical companies with new, previously unknown possibilities for optimized and innovative drug delivery systems (DDS) for their product development and production processes.
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany
+49 361 · 7447-601 | info@bm-t.de
bm|t beteiligungsmanagement thueringen gmbh
M.-Welsch-Str. 6a · 99084 Erfurt · Germany | +49 361·7447-601 | info@bm-t.de
Location: United States, New York
Investors 1
| Date | Name | Website |
| - | bm-t betei... | bm-t.de |
Mentions in press and media 6
| Date | Title | Description | Source |
| 02.02.2023 | Laxxon Medical to Participate in the BIO CEO & Investor ... | NEW YORK, NY / ACCESSWIRE / February 2, 2023 / Laxxon Medical, a pharma-technology company pioneerin... | accesswire... |
| 24.07.2022 | Triastek and Eli Lilly partner to 3D print gastrointestinal ... | Chinese drug 3D printing firm Triastek has announced a partnership with global pharmaceuticals compa... | 3dprinting... |
| 10.03.2022 | Evonik invests in Laxxon Medical for mass production of 3D p... | The venture capital arm of German chemicals firm Evonik has invested in Nevada-based 3D printed phar... | 3dprinting... |
| 10.01.2022 | Erste Kotierung am KMU-Segment der Schweizer Börse | Xlife Sciences bringt sorgfältig ausgewählte Frühphasen-Projekte in den vier Bereichen Technologie... | startuptic... |
| - | Settlement of the Swiss company Laxxon: 3D-printed medicines... | Laxxon optimises drug delivery thanks to a patented, innovative 3D screen printing process The tech... | bm-t.de/en... |
| - | Settlement of the Swiss company Laxxon: 3D-printed medicines... | Laxxon optimises drug delivery thanks to a patented, innovative 3D screen printing process The tech... | bm-t.de/en... |